Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen

Alternative dosage regimens for some anticancer therapies have been proposed in the midst of the SARS-COV-2 pandemic in order to protect the patients from attending to health care facilities. Flat-dosing of several immune-checkpoint inhibitors (ICIs), including nivolumab, have been established. Alth...

Descripción completa

Detalles Bibliográficos
Autores principales: Pous, Anna, Izquierdo, Cristina, Cucurull, Marc, Sánchez, Silvia, Lezcano, Clara, Domenech, Marta, Llobera, Laia, Plaja, Andrea, Moran, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107731/
https://www.ncbi.nlm.nih.gov/pubmed/34012801
http://dx.doi.org/10.21037/tlcr-20-1315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107731/
https://www.ncbi.nlm.nih.gov/pubmed/34012801
http://dx.doi.org/10.21037/tlcr-20-1315

Ejemplares similares